213 related articles for article (PubMed ID: 8567641)
1. The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX.
Lenting PJ; van de Loo JW; Donath MJ; van Mourik JA; Mertens K
J Biol Chem; 1996 Jan; 271(4):1935-40. PubMed ID: 8567641
[TBL] [Abstract][Full Text] [Related]
2. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding.
Lenting PJ; Christophe OD; Maat H; Rees DJ; Mertens K
J Biol Chem; 1996 Oct; 271(41):25332-7. PubMed ID: 8810297
[TBL] [Abstract][Full Text] [Related]
3. Blood coagulation factor IX residues Glu78 and Arg94 provide a link between both epidermal growth factor-like domains that is crucial in the interaction with factor VIII light chain.
Christophe OD; Lenting PJ; Kolkman JA; Brownlee GG; Mertens K
J Biol Chem; 1998 Jan; 273(1):222-7. PubMed ID: 9417068
[TBL] [Abstract][Full Text] [Related]
4. Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme.
Lenting PJ; ter Maat H; Clijsters PP; Donath MJ; van Mourik JA; Mertens K
J Biol Chem; 1995 Jun; 270(25):14884-90. PubMed ID: 7797466
[TBL] [Abstract][Full Text] [Related]
5. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
Ahmad SS; Walsh PN
Biochemistry; 2002 Sep; 41(37):11269-76. PubMed ID: 12220193
[TBL] [Abstract][Full Text] [Related]
6. Residues Phe342-Asn346 of activated coagulation factor IX contribute to the interaction with low density lipoprotein receptor-related protein.
Rohlena J; Kolkman JA; Boertjes RC; Mertens K; Lenting PJ
J Biol Chem; 2003 Mar; 278(11):9394-401. PubMed ID: 12522212
[TBL] [Abstract][Full Text] [Related]
7. Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII.
Lenting PJ; Donath MJ; van Mourik JA; Mertens K
J Biol Chem; 1994 Mar; 269(10):7150-5. PubMed ID: 8125924
[TBL] [Abstract][Full Text] [Related]
8. The binding of factor IXa to cultured bovine aortic endothelial cells. Induction of a specific site in the presence of factors VIII and X.
Stern DM; Nawroth PP; Kisiel W; Vehar G; Esmon CT
J Biol Chem; 1985 Jun; 260(11):6717-22. PubMed ID: 3922979
[TBL] [Abstract][Full Text] [Related]
9. Comparative interactions of factor IX and factor IXa with human platelets.
Ahmad SS; Rawala-Sheikh R; Walsh PN
J Biol Chem; 1989 Feb; 264(6):3244-51. PubMed ID: 2492533
[TBL] [Abstract][Full Text] [Related]
10. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
[TBL] [Abstract][Full Text] [Related]
11. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
[TBL] [Abstract][Full Text] [Related]
12. Insertion loop 256-268 in coagulation factor IX restricts enzymatic activity in the absence but not in the presence of factor VIII.
Kolkman JA; Mertens K
Biochemistry; 2000 Jun; 39(25):7398-405. PubMed ID: 10858287
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody to factor IX that inhibits the factor VIII:Ca potentiation of factor X activation.
Bajaj SP; Rapaport SI; Maki SL
J Biol Chem; 1985 Sep; 260(21):11574-80. PubMed ID: 3930478
[TBL] [Abstract][Full Text] [Related]
14. Antibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation: putative high-affinity Ca(2+)-binding site in the protease domain.
Bajaj SP; Sabharwal AK; Gorka J; Birktoft JJ
Proc Natl Acad Sci U S A; 1992 Jan; 89(1):152-6. PubMed ID: 1729682
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of coagulation factor X activation by platelet-bound factor IXa.
Rawala-Sheikh R; Ahmad SS; Ashby B; Walsh PN
Biochemistry; 1990 Mar; 29(10):2606-11. PubMed ID: 2110473
[TBL] [Abstract][Full Text] [Related]
16. Hydrophobic contact between the two epidermal growth factor-like domains of blood coagulation factor IX contributes to enzymatic activity.
Celie PH; Lenting PJ; Mertens K
J Biol Chem; 2000 Jan; 275(1):229-34. PubMed ID: 10617609
[TBL] [Abstract][Full Text] [Related]
17. Amphipathic helices support function of blood coagulation factor IXa.
Blostein MD; Rigby AC; Furie BC; Furie B; Gilbert GE
Biochemistry; 2000 Oct; 39(39):12000-6. PubMed ID: 11009614
[TBL] [Abstract][Full Text] [Related]
18. Baculovirus-mediated expression of the epidermal growth factor-like modules of human factor IX fused to the factor XIIIa transamidation site in fibronectin. Evidence for a direct interaction between the NH2-terminal epidermal growth factor-like module of factor IXa beta and factor X.
Astermark J; Sottile J; Mosher DF; Stenflo J
J Biol Chem; 1994 Feb; 269(5):3690-7. PubMed ID: 7906269
[TBL] [Abstract][Full Text] [Related]
19. A human alloantibody interferes with binding of factor IXa to the factor VIII light chain.
Fijnvandraat K; Celie PH; Turenhout EA; ten Cate JW; van Mourik JA; Mertens K; Peters M; Voorberg J
Blood; 1998 Apr; 91(7):2347-52. PubMed ID: 9516133
[TBL] [Abstract][Full Text] [Related]
20. Proteolytic interactions of factor IXa with human factor VIII and factor VIIIa.
Lamphear BJ; Fay PJ
Blood; 1992 Dec; 80(12):3120-6. PubMed ID: 1467518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
